ESPERITE (ESP) announces termination of negotiations regarding proposed sale of stem cell banking business to PBKM
June 25, 2019 16:59 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 25 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that the negotiations with Polski Bank Komórek Macierzystych S.A. (WSE: PBKM, “PBKM”)...
ESPERITE (ESP) negotiates 18-month extension for EUR 4,750,000 in unsecured convertible loan notes
June 14, 2019 02:54 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 14 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) is pleased to announce that it has agreed an extension of the maturity dates for EUR 4,750,000 in unsecured...
ESPERITE (ESP) resumes negotiations regarding proposed sale of stem cell banking business to PBKM
June 13, 2019 01:17 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 13 June 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that it has resumed negotiations with Polski Bank Komórek Macierzystych S.A. (WSE: PBKM,...
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whole Genome Sequencing for Consumer distribution.
June 04, 2019 04:18 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 04 June 2019 Jouvene’s new innovative offer will empower people with disease prevention, detection, diagnosis, treatment and management. With more than 10,000...
Esperite NV (ESP) introduces Jouvene - Swiss Medicine Quintessence, the first combined offer of Stem Cell long term storage and highly accurate Whle Genome Sequencing for Consumer distribution.
June 04, 2019 03:21 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 04 June 2019 Jouvene’s new innovative offer will empower people with disease prevention, detection, diagnosis, treatment and management. With more than 10,000...
ESPERITE (ESP) announces termination of MoU regarding proposed sale of stem cell banking business to PBKM due to lack of agreement on the terms of the sale
May 29, 2019 02:26 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 29 May 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that the Memorandum of Understanding (MoU) between Esperite and Polski Bank Komórek Macierzystych...
ESPERITE (ESP) announces listing measure by Euronext due to delay in publication of its 2018 annual report (as announced on 30 April 2019)
May 19, 2019 16:54 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 19 May 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today that it has received a notice from Euronext that its ordinary shares will be transferred to...
Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2018 and The Cell Factory cur-rent configuration.
May 13, 2019 01:17 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 13 May 2019 Esperite N.V. announced on 30 April 2019 that the publication of the Annual Report 2018 will be delayed. The Company has made significant progress...
Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2018
May 01, 2019 10:58 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 30 April 2019 Esperite N.V. announced on 22 February 2019 that the Company had signed an exclusive agreement regarding the potential acquisition (the Proposed...
ESPERITE (ESP) announces private placement of convertible loan notes to the European Select Growth Opportunities Fund
April 05, 2019 01:17 ET
|
Esperite N.V.
Amsterdam, The Netherlands – 05 April 2019 Esperite N.V. (Euronext: ESP, “Esperite”) announces today a EUR 250,000 private placement of 25 convertible notes with a principal amount of EUR 10,000...